Regional Court Munich grants PI to Regeneron against generics in Eylea case

Munich Regional Court granted a preliminary injunction against generics selling biosimilars with aflibercept, protecting...

Setback in UK after victory in Netherlands for Regeneron in Eylea case

UK and Netherlands courts rule on Regeneron’s EP691/EP306 aflibercept patents in Formycon/Samsung biosimilar cases, rev...